Effect of Ketamine on Cocaine-Induced Immunotoxicity in Rats

International Journal of Toxicology

Volumn 22, Issue 5, 2003, Pages 343-358

  Rofael, H Z ^a   Turka, R M ^a,b   Abdel Rahman, M S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Cocaine; Corticosterone; Ketamine; Norcocaine; SKF 525A; Th1 Th2

Indexed keywords

COCAINE; CORTICOSTERONE; CYTOCHROME P450; CYTOKINE; GAMMA INTERFERON; ILLICIT DRUG; INTERLEUKIN 10; KETAMINE; PROADIFEN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COCAINE DEPENDENCE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG ABUSE; DRUG METABOLISM; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; HISTOPATHOLOGY; IMMUNE SYSTEM; IMMUNOTOXICITY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MULTIPLE DRUG ABUSE; NEUTROPHILIA; NONHUMAN; RADIOIMMUNOASSAY; RAT; SPLEEN WEIGHT;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; OVIS ARIES;

EID: 0242415464     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1177/109158180302200503     Document Type: Article

References (58)

1. Anthony, J., D. Vlahov, K. Nelson, S. Cohn, J. Astemborski, and L. Solomon. 1991. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am. J. Epidemiol. 134:1175-1189.
2. Bagasra, O., and L. Forman. 1989. Functional analysis of lymphocytes subpopulations in experimental cocaine abuse. Clin. Exp. Immunol. 77:289-293.
3. Berney, S. 1974. Characterization of glucocorticoid-induced change in lymphocyte circulation in the rat. Clin. Res. 22:414A.
4. + lymphocytes. J. Immunol. 158:5569-5595.
5. Borradori, L., D. Castelli, E. Flueckiger, and U. Nydegger. 1990. Clinical significance of platelet-associated immunoglobulins in narcotic addicts with human immunodeficiency virus infection. Clin. Immunol. Immunopathol. 54:256-265.
6. Burday, M., and S. Martin. 1991. Cocaine-associated thrombocytopenia. Am. J. Med. 91:656-660.
7. Cha, S., H. Gu, K. Lee, M. Lee, S. Han, and T. Jeong. 2000. Immunotoxicity of ethyl carbamate in female BALB/c mice: Role of esterase and cytochrome P450. Toxicol. Lett. 115:173-181.
8. Chaisson, R., P. Bacchetti, D. Osmond, B. Brodie, M. Sande, and A. Moss. 1989. Cocaine use and HIV infection in intravenous drug users in San Francisco. J.A.M.A. 261:561-565.
9. Damianopoulos, E., and R. Carey. 1995. Evidence for N-methyl-D-aspartate receptor mediation of cocaine induced corticosterone release and cocaine conditioned stimulant effects. Behav. Brain Res. 68:219-228.
10. Daynes, R., and B. Araneo. 1989. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factor interleukin 2 and interleukin 4. Eur. J. Immunol. 19:2319-2325.
11. + lymphocytes by inhibiting IL-12 production. J. Immunol. 160:2231-2237.
12. Devi, B., and A. Chan. 1996. Cocaine-induced peroxidative stress in rat liver: Antioxidant enzymes and mitochondria. J. Pharmacol. Exp. Ther. 279:359-366.
13. Di Francesco, P., R. Falchetti, R. Gaziano, G. Lanzilli, L. Belogi, G. Ravagnan, and E. Garaci. 1994. Differential effects of short-term or prolonged cocaine exposure on peripheral blood cells in mice. Life Sci. 54:2015-2020.
14. Dillmann, J. 1998. Ketamine abuse-a new edge. Todays Surg. Nurse. 20:37-39.
15. Dorfman, R., and A. Dorfman. 1961. The relative thymolytic activities of corticoids using the overiectomized-adrenalectomized mouse. Endocrinology 69:283-291.
16. Fleshner, M., T. Deak, K. Nguyen, L. Watkins, and S. Maier. 2001. Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response. J. Immunol. 166:3813-3819.
17. Gorman, E., and R. Carroll. 2000. Substance abuse and HIV: Consideration with regards to methamphetamines and other recreational drugs for nursing practice and research. J. Assoc. Nurses AIDS Care 11:51-62.
18. Havas, H., M. Dellaria, G. Schiffman, E. Geller, and M. Adler. 1987. Effect of cocaine on the immune response and host resistance in BALB/c mice. Int. Arch. Allergy Appl. Immunol. 83:377-383.
19. Hill, G., J. Anderson, and E. Lyden. 1998. Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular cAMP accumulation. Anesth. Analg. 87:1015-1019.
20. Holsapple, M. 1995. The plaque-forming cell (PFC) response in immunotoxicology: An approach to monitoring the primary effector function of B lymphocytes. In Methods of immunotoxicology, eds. G. Burleson, J. Dean, and A. Munson, vol. 1, 71-108. New York: Wiley-Liss.
21. Holsapple, M., R. Matulka, E. Stanulis, and S. Jordan. 1993. Cocaine and immunocompetence: Possible role of reactive metabolites. Adv. Exp. Med. Biol. 335:121-126.
22. Jansen, K., and R. Darracot-Cankovic. 2001. The nonmedical use of ketamine, part two: A review of problem use and dependence. J. Psychoactive Drugs 33:151-158.
23. Jeong, T., S. Jordan, R. Matulka, E. Stanulis, E. Kaminski, and M. Holsapple. 1995a. Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response. J. Pharmacol. Exp. Ther. 272:407-416.
24. Jeong, T., S. Jordan, R. Matulka, E. Stanulis, S. Park, and M. Holsapple. 1996. Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450. J. Pharmcol. Exp. Ther. 276:1257-1265.
25. Jeong, T., R. Matulka, S. Jordan, K. Yang, and M. Holsapple. 1995b. Role of metabolism in cocaine-induced immunosuppression in splenocyte cultures from B6C3F1 female mice. Immunopharmacology 29:37-46.
26. Kump, D., R. Matulka, G. Burton, S. Jordan, and M. Holsapple. 1996. Alternations in splenocyte and thymocyte subpopulations in B6C3F1 mice exposed to cocaine plus diazinon. J. Pharmacol. Exp. Ther. 277:1477-1485.
27. Kump, D., E. Stanulis, M. Holsapple, D. Conrad, and J. Rosecrans. 1998. Cocaine-induced release of corticosterone mediates differential effects on T-helper 1 and T-helper 2 cell responses . Adv. Exp. Med. Biol. 437:189-198.
28. Labib, R., R. Turkall, and M. S. Abdel-Rahman. 2002. Inhibition of cocaine oxidative metabolism attenuates endotoxin's potentiation of cocaine mediated hepatotoxicity. Toxicology 179:9-19.
29. Livingston, A., and A. Waterman. 1978. The development of tolerance to ketamine in rats and the significance of hepatic metabolism. Br. J. Pharmac. 64:63-69.
30. Malmberg, K., V. Arulampalam, F. Ichihara, M. Petersson, K. Seki, T. Andersson, R. Lenkei, G. Masucci, S. Pettersson, and R. Kiessling. 2001. Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-κB activation. J. Immunol. 167:2595-2601.
31. Marietta, M., M. Vore, W. Way, and A. Trevor. 1977. Characterization of ketamine induction of hepatic microsomal drug metabolism. Biochem. Pharmacol. 26:2451-2453.
32. Markovic, S., and D. Murasko. 1990. Anesthesia inhibits poly I: C induced stimulation of natural killer cell cytotoxicity in mice. Clin. Immunol. Immunopathol. 56:202-209.
33. Mashaly, M., J. Trout, G. Hendricks, III, L. Al-Dokhi, and A. Gehad. 1998. The role of neuroendocrine immune interactions in the initiation of humoral immunity in chickens. Domestic Animal Endocrinol. 15:409-422.
34. Masteronardi, C., W. Yu, and S. McCann. 2001. Comparisons of the effects of anesthesia and stress on release of tumor necrosis factor-α, leptin, and nitric oxide in adult male rats. Exp. Biol. Med. 226:296-300.
35. Mattison, A., M. Ross, T. Wolfson, D. Franklin, and HNRC Group. 2001. Circuit party attendance, club drug use, and unsafe sex in gay men. J. Substance Abuse 13:119-126.
36. Matulka, R., S. Jordan, E. Stanulis, and M. Holsapple. 1996. Evaluation of sex-and strain-dependency of cocaine-induced immunosuppression in B6C3F1 and DBA/2 mice. J. Pharmacol. Exp. Ther. 279:12-17.
37. Moynihan, J., J. Karp, N. Cohen, and R. Cocke. 1994. Alterations in interleukin-4 and antibody production following pheromone exposure: Role of glucocorticoids. J. Neuroimmunol. 54:51-58.
38. Nishina, K., H. Akamatsu, K. Mikawa, M. Shiga, N. Mackawa, H. Obara, and Y. Niwa. 1998. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesth. Analg. 86:159-165.
39. Ou, D., M. Shen, and Y. Luo. 1989. Effects of cocaine on the immune system of balb/c mice. Clin. Immuonol. Immunopathol. 52:305-312.
40. + T cells in vitro. J. Immunol. 156:2406-2412.
41. Reinke, L., Y. Kotake, D. Moore, and A. Nanji. 1998. Free radical formation during ketamine anesthesia in rats-a cautionary note. Free Radic. Biol. Med. 24:1002-1006.
42. Robinson, S., R. Shah, B. Wong, V. Wong, and G. Farris. 1997. Immunotoxicological effects of benzene inhalation in male Sprague-Dawley rats. Toxicology 119:227-237.
43. Rofael, H., and M. S. Abdel-Rahman. 2002a. The role of ketamine on plasma cocaine pharmacokinetics in rat. Toxicol. Lett. 129:167-176.
44. Rofael, H., and M. S. Abdel-Rahman. 2002b. Development and validation of a high-performance liquid chromatography method for the determination of cocaine, its metabolites and ketamine. J. Appl. Toxicol. 22:123-128.
45. Rofael, H., R. Turkall, and M. S. Abdel-Rahman. 2003. Immunomodulation of cocaine and ketamine in postnatal rats. Toxicology 188:101-114.
46. Rome, E. 2001. It's a rave new world: Rave culture and illicit drug use in the young. Cleveland Clin. J. Med. 68:541-550.
47. Roytblat, L., D. Talmor, M. Rachinsky, L. Greemberg, A. Pekar, A. Appelbaum, G. Gurman, Y. Shapira, and A. Duvdenani. 1998. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth. Analg. 87:266-271.
48. Stanulis, E., S. Jordan, J. Rosecrans, and M. Holsapple. 1997a. Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone. Immunopharmacology 37:25-33.
49. Stanulis, E., R. Matulka, J. Jordan, J. Rosecrans, and M. Holsapple. 1997b. Role of corticosterone in enhancement of the antibody response after acute cocaine administration. Pharmacol. Exp. Ther. 280:284-291.
50. Takaono, M., T. Yogosawa, M. Okawa-Takatsuji, and S. Aotsuka. 2002. Effects of intravenous anesthetic on interleukin (IL)-6 and IL-10 production by lipopolysaccharide-stimulated mononuclear cells from healthy volunteers. Acta Anaesthesiol. Scand. 46:176-179.
51. Takenaka, I., M. Ogata, K. Koga, T. Matsumoto, and A. Shigematsu. 1994. Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology 80:402-408.
52. Temple, L., L. Butterworth, T. Kawabata, A. Munson, and K. White Jr. 1995. ELISA to measure SRBC-specific IgM: Methods and data evaluation. In Methods in immunotoxicology, eds. G. Burleson, J. Dean, and A. Munson, vol. 1, 137-157. New York: Wiley-Liss.
53. Temple, L., T. Kawabata, A. Munson, and K. White Jr. 1993. Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 21:412-419.
54. Torres, G., and C. Rivier. 1992. Differential effects of intermittent or continuous Exposure to cocaine on the hypothalamic-pituitary-adrenal axis and c-fos expression. Brain Res. 571:204-211.
55. Torres, G., C. Rivier, and F. Weiss. 1994. A ketamine mixture anesthetic inhibits neuroendocrine and behavioral consequences of cocaine administration. Brain Res. 656:33-42.
56. Tuchinda, M., R. Newcomb, and B. DeVald. 1972. Effect of prednisone treatment on the human immune response to keyhole limpet hemocyanin. Internat. Arch. Allergy Appl. Immunol. 42:533-544.
57. Vandebriel, R., C. Meredith, M. Scott, M. Van Dijk, and H. Van Loveren. 2000. Interleukin-10 is an unequivocal Th2 parameter in the rat, whereas interleukin-4 is not. Scand. J. Immunol. 52:519-524.
58. Yang, K., B. Kim, A. Munson, and M. Holsapple. 1986. Immunosuppression induced by chemicals requiring metabolic activation in mixed cultures of rat hepatocytes and murine splenocytes. Toxicol. Appl. Pharmacol. 83:420-429.